Type 2 Diabetes Trial, Recruiting NCT07329231 Sponsor: Qilu Hospital of Shandong University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07329231
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes (using a specific set of diagnostic standards from 1999) for less than 5 years
  • People whose HbA1c blood sugar level (a measure of average blood sugar over several months) is between 6.5% and 10%
  • People who have never used insulin therapy to manage their diabetes
  • People between 20 and 70 years of age

Who may not be able to join:

  • People who have experienced serious sudden complications from diabetes, such as diabetic ketoacidosis (a dangerous build-up of acids in the blood)
  • People with serious active or long-term conditions affecting the liver, kidneys, heart, brain and blood vessels, digestive system, or serious infectious diseases
  • People who are pregnant or planning to become pregnant in the near future
  • People with a known allergy to quinoa or bean-based products
  • People who have taken part in another dietary program or medication clinical trial within the past three months
  • People who have had a digestive or gastrointestinal illness in the two weeks before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 008618560083053

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
10 January 2021
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Glucose variability (MAGE) assessed by continuous glucose monitoring

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov